YMAB Option Call 20-12-2024 12 Option on Y mAbs Therapeutics
YMAB Stock | USD 10.01 0.27 2.63% |
YMAB Option Call 20-12-2024 12 is a CALL option contract on Y MAbs' common stock with a strick price of 12.5 expiring on 2024-12-20. The contract was last traded on 2024-11-18 at 11:22:33 for $0.36 and, as of today, has 9 days remaining before the expiration. The option is currently trading at an ask price of $0.75. The implied volatility as of the 11th of December 2024 is 9.0.
YMAB |
The strike price represents the predetermined price at which a call buyer can buy YMAB Stock. Call options may be purchased for speculation or sold for income purposes, or simply combined for various spread or combination strategies. If Y MAbs' price is above the strike price at expiry, the profit is the current Y MAbs' stock price, minus the strike price and the premium.
Rule 16 of 2024-12-20 Option Contract
The options market is anticipating that Y mAbs Therapeutics will have an average daily up or down price movement of about 0.0999% per day over the life of the option. With Y MAbs trading at USD 10.01, that is roughly USD 0.009995. If you think that the market is fully understating Y MAbs' daily price movement you should consider buying Y mAbs Therapeutics options at that current volatility level of 1.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on Y MAbs
An 'Out of The Money' option on YMAB has a strike price that YMAB Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Y MAbs' 'Out of The Money' options include buying the options if you expect a big move in Y MAbs' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | YMAB Option Call 20-12-2024 12 |
Expires On | 2024-12-20 |
Days Before Expriration | 9 |
Last Traded On | 2024-11-18 11:22:33 |
Open Interest | 1 |
Strike Price | 12.5 |
Last Traded At | 0.36 |
Current Price Spread | 0.0 | 0.75 |
Rule 16 Daily Up or Down | USD 0.009995 |
YMAB long CALL Option Payoff at expiration
Buying Y MAbs' call option is the simplest of option trades. A call option on YMAB Stock gives investors the right (but not the obligation) to purchase Y MAbs at the given strike price. Therefore Y MAbs' call intrinsic value or payoff at expiration depends on where the YMAB Stock price is relative to the call option strike price. The strike price of 12.5 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Y MAbs' price. Finally, at the break-even point of 12.5, the line crosses zero, and trading YMAB becomes profitable.
Profit |
Y MAbs Price At Expiration |
YMAB short CALL Option Payoff at expiration
By selling Y MAbs' call option, the investors signals his or her bearish sentiment. A short position in a call option written on Y MAbs will generally make money when the underlying price goes down. Therefore Y MAbs' call intrinsic value or payoff at expiration depends on where the YMAB Stock price is relative to the call option strike price. The strike price of 12.5 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Y MAbs' price. Finally, at the break-even point of 12.5, the line crosses zero, and trading YMAB becomes disadvantageous with no downside limits.
Profit |
Y MAbs Price At Expiration |
Y mAbs Therapeutics Available Call Options
Y MAbs' option chain is a display of a range of information that helps investors for ways to trade options on YMAB. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for YMAB. It also shows strike prices and maturity days for a Y MAbs against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Expiration | Current Spread | Last Price | |||
Call | YMAB Option Call 20-12-2024 12 | 1 | 2024-12-20 | 0.0 - 0.75 | 0.36 | Out |
Call | YMAB Option Call 20-12-2024 15 | 2 | 2024-12-20 | 0.0 - 0.75 | 0.1 | Out |
Call | YMAB Option Call 20-12-2024 17 | 100 | 2024-12-20 | 0.0 - 0.75 | 0.38 | Out |
Call | YMAB Option Call 20-12-2024 20 | 6 | 2024-12-20 | 0.0 - 0.75 | 1.0 | Out |
Y MAbs Corporate Management
Courtney Dugan | Vice Relations | Profile | |
Susan Smith | Senior Officer | Profile | |
MBBS MBA | Senior Officer | Profile | |
Torben MSc | VP Operations | Profile | |
Sue Smith | VP Officer | Profile |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Y mAbs Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Y MAbs. If investors know YMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Y MAbs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.921 | Quarterly Revenue Growth (0.1) | Return On Assets (0.12) | Return On Equity (0.25) |
The market value of Y mAbs Therapeutics is measured differently than its book value, which is the value of YMAB that is recorded on the company's balance sheet. Investors also form their own opinion of Y MAbs' value that differs from its market value or its book value, called intrinsic value, which is Y MAbs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Y MAbs' market value can be influenced by many factors that don't directly affect Y MAbs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Y MAbs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Y MAbs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Y MAbs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.